1. Home
  2. PLYM vs VALN Comparison

PLYM vs VALN Comparison

Compare PLYM & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLYM
  • VALN
  • Stock Information
  • Founded
  • PLYM 2011
  • VALN 2012
  • Country
  • PLYM United States
  • VALN France
  • Employees
  • PLYM N/A
  • VALN N/A
  • Industry
  • PLYM Real Estate Investment Trusts
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PLYM Real Estate
  • VALN Health Care
  • Exchange
  • PLYM Nasdaq
  • VALN Nasdaq
  • Market Cap
  • PLYM 993.0M
  • VALN 820.0M
  • IPO Year
  • PLYM 2017
  • VALN 2021
  • Fundamental
  • Price
  • PLYM $22.28
  • VALN $8.92
  • Analyst Decision
  • PLYM Hold
  • VALN Strong Buy
  • Analyst Count
  • PLYM 8
  • VALN 4
  • Target Price
  • PLYM $21.14
  • VALN $15.75
  • AVG Volume (30 Days)
  • PLYM 1.1M
  • VALN 19.3K
  • Earning Date
  • PLYM 11-10-2025
  • VALN 11-20-2025
  • Dividend Yield
  • PLYM 4.33%
  • VALN N/A
  • EPS Growth
  • PLYM 11196.82
  • VALN N/A
  • EPS
  • PLYM 2.04
  • VALN N/A
  • Revenue
  • PLYM $163,681,000.00
  • VALN $211,089,992.00
  • Revenue This Year
  • PLYM $1.88
  • VALN $6.86
  • Revenue Next Year
  • PLYM $9.24
  • VALN $11.85
  • P/E Ratio
  • PLYM $10.89
  • VALN N/A
  • Revenue Growth
  • PLYM N/A
  • VALN 13.48
  • 52 Week Low
  • PLYM $12.70
  • VALN $3.62
  • 52 Week High
  • PLYM $22.65
  • VALN $12.25
  • Technical
  • Relative Strength Index (RSI)
  • PLYM 58.48
  • VALN 41.42
  • Support Level
  • PLYM $21.95
  • VALN $8.53
  • Resistance Level
  • PLYM $22.38
  • VALN $8.92
  • Average True Range (ATR)
  • PLYM 0.17
  • VALN 0.25
  • MACD
  • PLYM -0.02
  • VALN 0.02
  • Stochastic Oscillator
  • PLYM 77.91
  • VALN 31.00

About PLYM Plymouth Industrial REIT Inc.

Plymouth Industrial REIT Inc is a full-service, vertically integrated, self-administered, and self-managed Maryland corporation. It is focused on the acquisition, ownership, and management of single and multi-tenant Class B industrial properties, including distribution centers, warehouses, and light industrial properties, located in secondary and primary markets across the United States. The company has one reportable segment, which is Industrial properties. The majority of its property portfolio is spread across Florida, Ohio, Indiana, Tennessee, Illinois and Georgia, among others. It receives income from the rental revenue through its properties.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: